
<DOC>
<DOCNO>
WSJ900516-0047
</DOCNO>
<DOCID>
900516-0047.
</DOCID>
<HL>
   Business Brief -- Atrix Laboratories Inc.:
   Company Files for Exchange
   Of Common-Stock Warrants
</HL>
<DATE>
05/16/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE C5
</SO>
<CO>
   ATRX
</CO>
<IN>
BUYBACKS, REDEMPTIONS, SWAP OFFERS (BBK)
</IN>
<LP>
   Atrix Laboratories Inc. said it has filed with the
Securities and Exchange Commission for an exchange offer
wherein 646,875 common-stock purchase warrants will be
offered by the company to holders of currently outstanding
common-stock purchase warrants.
   The company, based in Fort Collins, Colo., develops and
produces therapeutic drugs for periodontal disease.
</LP>
<TEXT>
   In the exchange, one new warrant will be swapped for each
outstanding warrant. Current warrant holders aren't required
to accept the offer.
   Each new warrant to be issued will entitle the holder to
purchase one share of common stock at the price of $2 until
Aug. 15, 1990, the company said.
   In over the counter trading yesterday, Atrix closed at
$3.438, bid.
</TEXT>
</DOC>